Save Younger People: Court To Centre On Black Fungus Drug Policy

The High Court said that those who have a better chance of survival, who are younger and hold the promise of the future have to be prioritised over the older generation who have lived their lives and others may not be dependent.

The Delhi High Court on Tuesday asked the Centre to frame the policy on the distribution of the Liposomal Amphotericin B, a drug used in the treatment of black fungus. It added that younger people and those with better chances of survival should be prioritised, instead of older ones who have lived a full life. A Division Bench of Justices Vipin Sanghi and Jasmeet Singh asked the Centre to frame policy and file a status report on this regard and listed the matter for Friday. The court asked the Centre to take a policy decision on the manner of medicine Amphotericin B drug, used for treating black fungus, should be made available to patients making it clear that any decision that has to be taken in this regard should be taken with inputs from medical professionals. The court also suggested patients should be prioritised -- who have a better chance to survive so at least some lives can be saved. The High Court said that those who have a better chance of survival, who are younger and hold the promise of the future have to be prioritised over the older generation who have lived their lives and others may not be dependent.